Nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium phase multiphasic CT images in the
Jae-Joon Chung1, Jeong Sik Yu, Joo Hee Kim
1Department of Radiology and Research Institute of Radiological Science, Yongdong Severance Hospital, Yonsei University College of Medicine, 162, Eonju-ro, Gangnam-gu, Seoul 135-720, Korea.
Objective:
The objective of this study was to investigate the outcome and clinical implications of nonhypervascular hypoattenuating nodules observed on portal or equilibrium phase CT images of cirrhotic livers.
Materials And Methods:
One hundred one cirrhotic patients (male:female = 69:32) with hypoattenuating nodules observed on initial portal or equilibrium phase CT images were retrospectively evaluated by follow-up CT performed 6-66 months after the initial CT examination. Depending on the background nodularity, patients were separated into macronodular (n = 33, 288 nodules) and micronodular (n = 68, 346 nodules) cirrhotic groups. Each nodule was categorized as category I (enlarged) or category II (stable). Nodule categories were correlated with the initial lesion size and the pattern of background cirrhosis.
Results:
The frequency of category I nodules was higher in patients with micronodular cirrhosis (40%) than in those with macronodular cirrhosis (27%) (p = 0.001). Category I nodules were significantly larger than category II nodules in patients with micronodular cirrhosis (p < 0.001). The doubling times of category I nodules had no statistical difference between patients with micronodular or macronodular cirrhosis (p = 0.954). Of the category I nodules in patients with micronodular cirrhosis, 8.6% showed malignant changes.
Conclusion:
More careful attention should be paid to large nodules in patients with micronodular cirrhosis because of the potentially greater risk of malignancy, and small hypoattenuating nodules should be more often followed up in shorter intervals than large nodules.
More Related Videos
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024
07:47Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Related Concept Videos
Cirrhosis I: Introduction
Portal Hypertension
Cirrhosis II: Pathophysiology
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
